摘要
目的探讨局部注射给药联合口服康复新液治疗浅表淋巴结结核的临床疗效。方法 70例浅表淋巴结结核患者按随机数字表法分为对照组及观察组,每组35例。两组患者均给予全身抗结核治疗,对照组再采用手术治疗,观察组同时行局部注射给药(链霉素+异烟肼)联合口服康复新液治疗。对比两组患者临床疗效,观察治疗后2年内复发情况。结果观察组总有效率为88.57%(31/35),稍高于对照组的85.71%(30/35);治疗后2年内观察组复发率为8.57%(3/35),低于对照组的17.14%(6/35),但两组总有效率及复发率比较,差异均无统计学意义(P>0.05)。结论在全身抗结核治疗的基础上,局部注射给药联合口服康复新液治疗浅表淋巴结结核的疗效与手术治疗相似,但可避免手术治疗所导致的并发症。
Objective To explore the clinical efficacy of local injection combined with oral administration of Kangfuxin solution for the treatment of superficial tuberculous lymphadenitis. Methods Seventy patients with superficial tuberculous lymphadenitis were divided into control group and observation group by random number table ,with 35 cases in each group. The patients in the two groups were given systemic anti-tuberculosis therapy. Moreover, control group received the surgical therapy, while observation group received local injection with streptomycin and isoniazid combined with oral administration of Kangfuxin solution. The clinical efficacies were compared between two groups, and the recrudescence was observed within 2 years after treatment. Results The total effective rate of observation group was 88.57% （31/35） and was slightly higher than that of control group（ 85.71% ,30/35 ）. Within 2 years after treatment,the recurrence rate of observation group was 8.57% （3/35） and was lower than that of control group（ 17.14% ,6/35 ）. No significant difference was observed in the total effective rate or recurrence rate between two groups （ P 〉 0.05）. Conclusion On the basis of systemic anti-tuberculosis therapy, local injection combined with oral administration of Kangfuxin solution obtains similar efficacy as the surgical therapy for the treatment of superficial tuberculous lymphadenitis, and can avoid the complications caused by surgical therapy.
出处
《广西医学》
CAS
2016年第2期187-188,193,共3页
Guangxi Medical Journal
基金
河北省保定市计划内科研(13ZF132)
关键词
结核
淋巴结
浅表
康复新液
局部注射
手术
Tuberculosis,Lymph node,Superficial,Kangfuxin solution,Local injection,Surgery
